Leadership Team

Larry Heaton

Chief Executive Officer

Larry has more than 35 years of executive leadership and operations experience from the therapeutic, medical device and biotechnology industries, with an extensive focus on business and product development and commercialization at both large cap and early-stage medical device companies . 

Most recently, Larry was President, Chief Executive Officer and Director of Flowonix, Inc., a privately held company marketing implantable drug-delivery systems for the management of pain and spasticity. Prior to that, he was President, Chief Executive Officer and Director of Cardiox Corporation, a privately held company that developed and marketed drug-device combination products for the structural heart and liver diagnostics markets. He also has served as President, Chief Executive Officer and Chairman of the board of Vioptix Inc., a privately held company in the tissue oximetry field, President, Chief Executive Officer and Director of Curon Medical, Inc., a public company marketing products for the treatment of gastrointestinal disorders, and President, Chief Executive Officer and Director of Response Genetics, Inc., an applied genomics start-up firm providing gene expression services in the oncology market.

His earlier career spanned 18 years at United States Surgical Corporation (USSC), a leading manufacturer of innovative wound closure and advanced surgical products, serving in roles of increasing responsibility in Sales, Marketing and General Management. His career at USSC culminated in his serving as President and Chief Operating Officer of USSC from 1998 through 2000.

Larry was awarded a Bachelor of Arts degree from Eastern Illinois University, and is an inventor on several U.S. patents. He has served as a member of the board of several international medical societies and foundations, including the MITAC Board for the commercialization of NASA technology via partnerships with the medical industry.

Ann Cotter, CPA

Chief Financial Officer

Ann has primary responsibility for planning, implementation, and management of Zomedica’s finance activities, including business planning, budgeting, forecasting and negotiations. She  served as the Company’s Vice President of Finance from August 2018 until October 2020, when she was promoted to her current role. 

Throughout her career, Ann has held various consulting, controllership and Chief Financial Officer roles for both private and publicly held companies and has public accounting experience in both audit and tax services. She served as Chief Financial Officer of American Fence Company, a fence rental, installation and manufacturing company, from April 2018 through August 2018. She has also served as Corporate Controller of ProMotion Technology Group, a digital solutions provider, from September 2014 through August 2017. Ann holds a Master of Taxation from Capital University Law School and a Bachelor of Arts in Economics and Spanish from Capital University. She is a Certified Public Accountant, licensed in Ohio since 1996.

Adrian Lock

Vice President and General Manager                                                                                      

Adrian joined the Zomedica leadership team in October, 2021 when the company he founded in 2009, Pulse Veterinary Technologies, LLC (“PulseVet”) was acquired.  He brings over 30 years of human and veterinary healthcare and biotechnology sales, marketing, and executive leadership experience to the organization.

Prior to PulseVet, Adrian was Vice-President of Sales and Marketing with Sanuwave, where he devoted his energy and resources to developing and commercializing shock wave technology. While at Sanuwave he took over the veterinary division, allowing him to combine his training and background with his lifelong passion for animals. In 2009 the veterinary division of Sanuwave split to form PulseVet.  As Director of Global Marketing with CryoLife, he launched BioGlue ® Surgical Adhesive in 2001. BioGlue is a life-saving product now recognized as the leading surgical adhesive in worldwide clinical use for indications in cardiovascular, neurological, and soft tissue surgeries. 

Prior to starting his healthcare career, Adrian served in the US Navy as a nuclear trained submarine officer, where he was awarded a Navy Achievement Medal and a Navy Commendation Medal for his service aboard 2 submarines, USS Flying Fish (SSN673), USS Scranton (SSN756), and as a Watch Officer at ComSubLant. 

Adrian holds a BS degree in Engineering Science from Vanderbilt University, which he attended on a Navy ROTC scholarship. 

In his free time Adrian enjoys playing guitar, fitness/outdoor activities, and spending time with his wife, Rhonda, four daughters, two granddaughters, two dogs, and cat.

Greg Blair, MBA

Vice President of Business Development & Strategic Planning

Greg is a dynamic life sciences leader with experience across business development, commercial, product development and finance roles. He is responsible for building and executing an external innovation strategy to maximize shareholder value. 

Greg’s focus is on creating value-added partnerships and acquiring differentiated technology that helps Zomedica’s customers thrive in practice and supports their mission to enhance the veterinary care experience for pets and pet parents. 

Greg joined Zomedica from Elanco Animal Health, where he was known for his collaborative approach to creating strategic alliances that built trust and confidence with partners across the industry.  While at Elanco, Greg delivered multiple successful transactions, including acquisitions, divestitures, strategic alliances, equity investments and licensing transactions.

He has dedicated his career to leading teams that deliver innovative solutions for customers with companies such as Johnson and Johnson, Intuitive Surgical and Enteromedics. Greg’s passion for innovation and pursuit of technologies that solve unmet needs, improve clinicians’ practices and enrich patient lives led him to launch numerous innovative products throughout his career. 

Outside of work, Greg enjoys spending quality time with his wife and young son, as well as their Beauceron, Poscoe. He is a private pilot, and the family enjoys taking trips around the eastern US to anywhere with a beach and warm weather.

Mike Schilk

Vice President of Sales

Mike Schilk joined Zomedica with more than 25 years of global sales and business development experience in both the human and animal health markets, including time at multiple Fortune 500 companies. Throughout his career, Mike has been responsible for leading the commercial launch of pharmaceutical and diagnostic products across North America, Europe, Asia, and Latin America and has held senior roles at Abbott Laboratories and Pfizer Inc., among others.

Prior to Zomedica Mike has demonstrated medical sales leadership over the past twenty-five years for Arthrex, IBM, Pfizer Inc., and Abbott Laboratories. At Abbott Laboratories he was responsible for the growth and development of more than 100 sales professionals and managers serving a $300 million business unit, followed by positions as Vice President of Sales & Business Development at I4cInnovations and General Manager US & International Endodontics at SS White Dental. Mr. Schilk joined Zomedica in 2018 and has been essential in building the internal sales organization in anticipation of the commercial release of TRUFORMA™.

Mike graduated with a Bachelor of Science degree in economics from the University of Arizona. Outside of work, he enjoys international travel, live music and spending time with his son and daughter.


Ashley Wood, PhD

Senior Director of Research and Development 

Ashley joined Zomedica in 2019 to facilitate the development of BAW technology for use in veterinary medicine. She now leads the company’s research and development activities. Ashley’s expertise is in the areas of molecular biology, cell biology, imaging techniques and biochemistry.

Prior to her current role, Ashley was part of the R&D group at Swift Biosciences, where she was responsible for creating market viable products as the lead scientist in the advancement of next generation sequencing assays. Her responsibilities included assay development, bioinformatic analysis, and transfer to manufacturing.

Ashley also served as a research assistant professor and completed as postdoctoral research fellowship (awarded by the American Cancer Society) in the Cell & Molecular Biology department at Northwestern University’s Feinberg School of Medicine. She has co-authored several papers that have appeared in industry-prominent journals.

Ashley graduated with honors from Duke University with a degree in biochemistry, and earned a PhD in molecular biology from Johns Hopkins University. She is the mother of two young boys, and when she’s not transporting them to hockey, baseball, or other activities, she enjoys cooking, running, and spending time outdoors.

Evan St. Peter, MBA

Senior Director of Technology Innovation

Evan joined Zomedica in September of 2018 to lead the development of a cloud-based data platform to capture data from Zomedica’s diagnostic devices. This platform is known as MyZomedicaTM today. He now leads the company’s technology innovation for both Zomedica’s customer facing digital technology as well as Zomedica’s internal technology needs.

Prior to joining Zomedica, Evan was part of the Connected Care team within Stryker’s Medical and Surgical Division, where he helped lead delivery of Stryker’s customer facing IoT and machine learning application called Smart Equipment Management. During his time at Stryker, he was responsible for leading Agile application development across onshore and offshore development teams as well as the statistical validation of supervised machine learning models to identify surgical devices that would benefit from preventative maintenance. In addition to his time at Stryker, Evan brings operations and enterprise IT experience from his time at MPI Research, where he held roles of increasing responsibility throughout his career there.

Evan holds a Bachelor of Science in Biology from Northern Michigan University and a Master of Business Administration from Western Michigan University. He is the father of two boys. He and his wife enjoy family camping and home DIY, and he is an avid cyclist.


Angy Guerrant

Senior Director of PMO and Regulatory Affairs

As Zomedica’s first employee, Angy has worn many hats at the company, all with a focus on optimizing resources to facilitate its commercial success. She is dedicated to keeping product innovations on track, within budget, and consistent with organizational goals in order to realize market launch objectives as quickly and profitably as possible. 

With nearly 20 years of experience, her career is rooted in successfully leading corporate business initiatives that directly impact the bottom line, as well as providing proactive and timely regulatory guidance throughout the planning and execution of product development.

During her tenure with MPI Research, she increased revenue by $800K per month through establishing and enforcing key policies while capturing scope changes that impacted budgets. She quickly earned a reputation for expertly sourcing and forecasting capacity over a diverse project portfolio, managing 544 research rooms and more than 700 employees across 1,800 active projects ranging in duration from months to years. She is an ace at all levels of procurement, including vendor evaluation and selection, and has served as the primary line of support for sales teams throughout the United States, Europe, and Asia Pacific regions.

Angy holds a Bachelor of Science in biomedical science from Western Michigan University and is a Certified Laboratory Animal Technologist. She has a passion for travel and new adventures that merge cultural experiences and historical sites, an interest discovered during her service in the Navy where she was engaged in humanitarian efforts across Europe. She spends her remaining downtime with her family and two pups, Otto and Knox.